Organisation paid for research Program year 2025 Source: CMS Open Payments

Ars - Maitland Clinical Research Unit

Neither a doctor nor a teaching hospital

Research payments

$60,815

139 payments

Through program year 2025, Ars - Maitland Clinical Research Unit is reported as receiving $60,815 in research payments, across 139 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$4,352	88
2024	Research	$56,464	51

Breakdown

Who paid Research payments · program years 2024–2025

Incyte Corporation $60,815 139 payments

Studies the money was for Research payments · program years 2024–2025

A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, EfficacyAnd Safety of Ruxolitinib Cream in Participants with Prurigo Nodularis $55,745 38 payments
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa $2,993 47 payments
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa $1,359 41 payments
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa $719 13 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.